Walgreens Boots Alliance, Inc. (WBA)

$11.82

+0.31

(+2.69%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $11.39
    $11.82
    $11.82
    downward going graph

    3.64%

    Downside

    Day's Volatility :3.64%

    Upside

    0.0%

    downward going graph
  • $10.69
    $28.23
    $11.82
    downward going graph

    9.56%

    Downside

    52 Weeks Volatility :62.13%

    Upside

    58.13%

    downward going graph

Returns

PeriodWalgreens Boots Alliance, Inc.Sector (Consumer Staples)S&P500
3 Months
-34.97%
2.8%
5.9%
6 Months
-49.63%
7.0%
10.4%
1 Year
-62.69%
2.3%
18.2%
3 Years
-75.64%
8.6%
22.1%

Highlights

Market Capitalization
9.9B
Book Value
$15.8
Dividend Share
1.46
Dividend Yield
8.95%
Earnings Per Share (EPS)
-6.74
PEG Ratio
1.98
Wall Street Target Price
11.55
Profit Margin
-3.99%
Operating Margin TTM
0.3%
Return On Assets TTM
1.3%
Return On Equity TTM
-55.97%
Revenue TTM
145.5B
Revenue Per Share TTM
168.63
Quarterly Revenue Growth YOY
2.6%
Gross Profit TTM
27.1B
EBITDA
4.0B
Diluted Eps TTM
-6.74
Quarterly Earnings Growth YOY
1.92
EPS Estimate Current Year
2.63
EPS Estimate Next Year
1.85
EPS Estimate Current Quarter
0.68
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Hold
    7%Buy
    59%Hold
    33%Sell
Based on 27 Wall street analysts offering stock ratings for Walgreens Boots Alliance, Inc.(by analysts ranked 0 to 5 stars)
Based on 27 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
2
2
2
Hold
16
16
16
Sell
9
9
8

Analyst Forecast

What analysts predicted

Downside of 2.28%

Current $11.82
Target $11.55

Company Financials

FY18Y/Y Change
Revenue
131.5B
↑ 11.27%
Net Income
5.0B
↑ 23.2%
Net Profit Margin
3.82%
↑ 0.37%
FY19Y/Y Change
Revenue
136.9B
↑ 4.05%
Net Income
4.0B
↓ 20.74%
Net Profit Margin
2.91%
↓ 0.91%
FY20Y/Y Change
Revenue
139.5B
↑ 1.95%
Net Income
456.0M
↓ 88.55%
Net Profit Margin
0.33%
↓ 2.58%
FY21Y/Y Change
Revenue
132.5B
↓ 5.04%
Net Income
1.3B
↑ 191.23%
Net Profit Margin
1.0%
↑ 0.67%
FY22Y/Y Change
Revenue
132.7B
↑ 0.15%
Net Income
4.3B
↑ 226.58%
Net Profit Margin
3.27%
↑ 2.27%
FY23Y/Y Change
Revenue
139.1B
↑ 4.81%
Net Income
-3.1B
↓ 171.02%
Net Profit Margin
-2.21%
↓ 5.48%
Q1 FY23Q/Q Change
Revenue
34.9B
↑ 4.43%
Net Income
537.0M
↓ 114.05%
Net Profit Margin
1.54%
↑ 12.99%
Q2 FY23Q/Q Change
Revenue
35.4B
↑ 1.59%
Net Income
-52.0M
↓ 109.68%
Net Profit Margin
-0.15%
↓ 1.69%
Q3 FY23Q/Q Change
Revenue
35.4B
↑ 0.02%
Net Income
-180.0M
↑ 246.15%
Net Profit Margin
-0.51%
↓ 0.36%
Q4 FY23Q/Q Change
Revenue
36.7B
↑ 3.63%
Net Income
-67.0M
↓ 62.78%
Net Profit Margin
-0.18%
↑ 0.33%
Q1 FY24Q/Q Change
Revenue
37.1B
↑ 0.94%
Net Income
-5.9B
↑ 8716.42%
Net Profit Margin
-15.94%
↓ 15.76%
Q2 FY24Q/Q Change
Revenue
36.4B
↓ 1.89%
Net Income
344.0M
↓ 105.82%
Net Profit Margin
0.95%
↑ 16.89%
FY18Y/Y Change
Total Assets
68.1B
↑ 3.2%
Total Liabilities
41.4B
↑ 9.81%
FY19Y/Y Change
Total Assets
68.2B
↑ 0.17%
Total Liabilities
43.4B
↑ 4.85%
FY20Y/Y Change
Total Assets
87.2B
↑ 27.75%
Total Liabilities
66.0B
↑ 52.0%
FY21Y/Y Change
Total Assets
81.3B
↓ 6.76%
Total Liabilities
57.5B
↓ 12.98%
FY22Y/Y Change
Total Assets
90.1B
↑ 10.87%
Total Liabilities
59.7B
↑ 3.92%
FY23Y/Y Change
Total Assets
96.6B
↑ 7.22%
Total Liabilities
68.1B
↑ 14.1%
Q1 FY23Q/Q Change
Total Assets
100.5B
↑ 8.19%
Total Liabilities
70.9B
↑ 4.03%
Q2 FY23Q/Q Change
Total Assets
98.6B
↓ 1.87%
Total Liabilities
69.1B
↓ 2.53%
Q3 FY23Q/Q Change
Total Assets
96.6B
↓ 2.0%
Total Liabilities
68.1B
↓ 1.37%
Q4 FY23Q/Q Change
Total Assets
97.8B
↑ 1.24%
Total Liabilities
70.1B
↑ 2.83%
Q1 FY24Q/Q Change
Total Assets
84.2B
↓ 13.92%
Total Liabilities
68.8B
↓ 1.75%
Q2 FY24Q/Q Change
Total Assets
83.0B
↓ 1.45%
Total Liabilities
67.6B
↓ 1.87%
FY18Y/Y Change
Operating Cash Flow
8.3B
↑ 13.98%
Investing Cash Flow
-5.5B
↑ 552.55%
Financing Cash Flow
-5.3B
↓ 59.06%
FY19Y/Y Change
Operating Cash Flow
5.6B
↓ 32.32%
Investing Cash Flow
-2.3B
↓ 58.06%
Financing Cash Flow
-3.0B
↓ 42.46%
FY20Y/Y Change
Operating Cash Flow
5.5B
↓ 1.97%
Investing Cash Flow
-1.3B
↓ 43.78%
Financing Cash Flow
-4.6B
↑ 52.51%
FY21Y/Y Change
Operating Cash Flow
5.6B
↑ 1.29%
Investing Cash Flow
4.1B
↓ 413.96%
Financing Cash Flow
-9.0B
↑ 94.45%
FY22Y/Y Change
Operating Cash Flow
3.9B
↓ 29.81%
Investing Cash Flow
-1.1B
↓ 126.13%
Financing Cash Flow
-1.5B
↓ 83.41%
FY23Y/Y Change
Operating Cash Flow
2.3B
↓ 42.09%
Investing Cash Flow
-3.1B
↑ 190.79%
Financing Cash Flow
-887.0M
↓ 40.83%
Q1 FY23Q/Q Change
Operating Cash Flow
746.0M
↑ 51.32%
Investing Cash Flow
-5.4B
↓ 392.84%
Financing Cash Flow
2.4B
↓ 494.82%
Q2 FY23Q/Q Change
Operating Cash Flow
-20.0M
↓ 102.68%
Investing Cash Flow
334.0M
↓ 106.14%
Financing Cash Flow
-1.2B
↓ 150.44%
Q3 FY23Q/Q Change
Operating Cash Flow
1.0B
↓ 5295.0%
Investing Cash Flow
155.0M
↓ 53.59%
Financing Cash Flow
-1.5B
↑ 22.38%

Technicals Summary

Sell

Neutral

Buy

Walgreens Boots Alliance, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
-26.5%
-49.63%
-62.69%
-75.64%
-79.09%
Petmed Express Inc
Petmed Express Inc
-3.45%
-41.58%
-72.59%
-86.11%
-75.47%
Bimi International Medical Inc
Bimi International Medical Inc
-2.57%
-56.42%
-57.84%
-97.67%
-98.95%
High Tide Inc
High Tide Inc
-15.53%
-3.65%
45.67%
-69.82%
-79.44%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
27.42
NA
1.98
2.63
-0.56
0.01
0.09
15.8
Petmed Express Inc
Petmed Express Inc
1191.0
NA
2.58
-0.19
-0.07
-0.02
0.16
4.73
Bimi International Medical Inc
Bimi International Medical Inc
NA
NA
NA
0.0
-1.04
-0.13
NA
1.31
High Tide Inc
High Tide Inc
NA
NA
NA
-0.03
-0.23
0.02
NA
1.76
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc.
Hold
$9.9B
-79.09%
27.42
-3.99%
Petmed Express Inc
Petmed Express Inc
Sell
$80.8M
-75.47%
1191.0
-2.66%
Bimi International Medical Inc
Bimi International Medical Inc
NA
$18.8M
-98.95%
NA
-83.2%
High Tide Inc
High Tide Inc
Buy
$156.7M
-79.44%
NA
-6.82%

Insights on Walgreens Boots Alliance, Inc.

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 37.05B → 36.35B (in $), with an average decrease of 1.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -5.90B → 344.0M (in $), with an average increase of 1817.2% per quarter

  • Vs HITI

    In the last 1 year, High Tide Inc has given 45.7% return, outperforming this stock by 108.4%

  • Vs HITI

    In the last 3 years, Walgreens Boots Alliance, Inc. has experienced a drawdown of -75.6%, however High Tide Inc resisted the overall trend and outperformed by 5.8%

Institutional Holdings

  • Vanguard Group Inc

    9.53%

  • BlackRock Inc

    7.89%

  • State Street Corporation

    4.19%

  • Capital World Investors

    3.37%

  • Geode Capital Management, LLC

    2.19%

  • Amvescap Plc.

    2.00%

Corporate Announcements

  • Walgreens Boots Alliance, Inc. Dividends March,2024

    In the quarter ending March,2024. Walgreens Boots Alliance, Inc. has declared dividend of $0.25

    Read More

Company Information

walgreens boots alliance is the first global pharmacy-led, health and wellbeing enterprise. the company was created through the combination of walgreens and alliance boots in december 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. the company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the usa and europe. including its equity method investments, walgreens boots alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. the company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, he

Organization
Walgreens Boots Alliance, Inc.
Employees
206000
CEO
Mr. Stefano Pessina
Industry
Retail Trade

Discover More

FAQs